Goldman Sachs Releases Updated US Director’s Cut List

Goldman Sachs has released its latest update to the US Director’s Cut list, which includes a selection of high-conviction, Buy-rated stocks. The updated list now features Vertex Pharmaceuticals, which has been added, while Interactive Brokers has been removed from the roster.

The US Director’s Cut list typically includes 20 to 25 stocks that are chosen based on bottom-up fundamental analysis, emphasizing differentiated views and attractive risk-adjusted return potential. The updates occur monthly, and changes in the list do not necessarily indicate a shift in analyst ratings.

© 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Source: KLEA News